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A B S T R A C T
Introduction. More than 70,000 new cases of bladder cancer are diagnosed in the United States annually; with 75%
being non-muscle-invasive (NMIBC). Research examining sexual dysfunction in bladder cancer survivors is limited,
and previous studies have focused on cystectomy patients.
Aims. To evaluate the impact of sexual dysfunction on NMIBC survivors.
Methods. Mixed-methods data collection integrated a quantitative survey (Study 1; n = 117) and semi-structured
qualitative interviews (Study 2; n = 26) from a non-overlapping sample of NMIBC survivors. We performed
descriptive and classiﬁcation and regression tree (CART) analyses of survey data and qualitative analysis of
interviews.
Main Outcome Measures. Self-reported sexual activity, interest in sex, and physiologic symptoms (e.g., male
erectile/ejaculatory difﬁculties, female vaginal dryness) over the previous 4 weeks; partner communication about
sexuality; contamination concerns; illness intrusiveness.
Results. Participants in these studies averaged 65 years of age (mean and median) and were male (77%), white (91%),
and married (75%). Survey (Study 1) results linked NMIBC treatment to sexual symptoms and relationship issues.
Many participants reported sexual inactivity (38.8%). Sexually active participants reported erectile difﬁculties
(60.0%), vaginal dryness (62.5%), and worry about contaminating partner with treatment agents (23.2%). While
almost one-half reported the usefulness of talking with partners about sexual function, only one-ﬁfth of participants
reported sharing all concerns with their partners. CART analysis supported the importance of communication.
One-half of interviewees (Study 2) reported sexual dysfunction. Two-thirds reported negative impacts on their
relationships, including perceived loss of intimacy and divorce; over one-third were sexually inactive for fear of
contaminating their partner or spreading NMIBC.
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Conclusions. Survivors’ sexual symptoms may result from NMIBC, comorbidities, or both. These results
inform literature and practice by raising awareness about the frequency of symptoms and the impact on NMIBC
survivors’ intimate relationships. Further work is needed to design symptom management education programs to
dispel misinformation about contamination post-treatment and improve quality of life. Kowalkowski MA,
Chandrashekar A, Amiel GE, Lerner SP, Wittmann DA, Latini DM, and Goltz HH. Examining sexual
dysfunction in non-muscle-invasive bladder cancer: Results of cross-sectional mixed-methods research. Sex
Med 2014;2:141–151.
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Introduction
Bladder cancer (BlCa) is the 4th most commonform of cancer in the United States with over
70,000 new cases diagnosed annually [1]. Any
malignancy of the pelvis, including BlCa, may lead
to sexual dysfunction among men or women,
deﬁned as a decrease in sexual desire or variability
of the sexual response cycle (i.e., excitement,
plateau, orgasm, resolution) due to psychogenic or
organic causes. Previous studies have demon-
strated that radical cystectomy and urinary diver-
sion, mainstays of surgical management for
muscle-invasive bladder cancer, result in increased
incidence of sexual dysfunction [2]. However,
non-muscle-invasive bladder cancer (NMIBC)
accounts for approximately 75% of incident
bladder cancers [3]. Sexual dysfunction has not
been well-studied among NMIBC survivors, who
frequently undergo surveillance and various intra-
vesical therapies.
Most treatments for BlCa cause substantial side
effects that increase as treatments become more
invasive and may persist. For example, Bacillus
Calmette–Guérin (BCG) treatment may cause
pain, dysuria, and urinary frequency [4,5]. Men
may also experience erectile difﬁculties, which may
resolve after BCG therapy ends [5]. Since BlCa is
primarily a male disease, the limited literature does
not include data on sexual dysfunction in women
receiving BCG therapy. However, while sexual
dysfunction has traditionally been perceived as
predominately affecting men, more recent data
suggests that a larger percentage of women (43%
vs. 31% of men) are affected by sexual dysfunction
(e.g., decreased vaginal lubrication, dyspareunia,
diminished arousal, or difﬁculty achieving orgasm)
[6].
Transurethral cystoscopy with either rigid or
ﬂexible instruments is currently the most common
method of monitoring for bladder cancer recur-
rence and progression. Rigid cystoscopy has been
shown to cause transient impairment of sexual
function and temporary decrease in libido among
sexually-active patients [7]. Yet, the long-term
effects of repeated surveillance cystoscopy have
not been fully evaluated.
Quality of life (QOL) is critical to consider
when discussing both the direct effects of cancer
and those associated with subsequent treatment.
Increasingly, sexual dysfunction has become an
important component of QOL measurement,
particularly in the evaluation of genitourinary
malignancies [8]. Among men, sexual dysfunction,
speciﬁcally ED, represents a signiﬁcant cost to the
healthcare system [9]. However, existing QOL
measures do not fully account for the detrimental
psychological effects of sexual dysfunction experi-
enced by men and women (e.g., poor self-image,
diminished self-esteem, depression mental stress
and negative effects on personal relationships).
This is particularly true when considering the
acute onset of sexual dysfunction secondary to
cancer or its treatment. One study using focus
groups of men who had undergone deﬁnitive
therapy for localized prostate cancer showed that
physiologic sexual dysfunction impacted the
quality of sexual intimacy, everyday interactions
with women, sexual imagining and fantasy life, and
self-perceptions of masculinity [10].
Aim
The literature on psychological burden of disease
among bladder cancer survivors is limited and
focuses primarily on muscle-invasive disease survi-
vors. The few existing studies of NMIBC survivors
focus primarily on male survivors. Thus, the goal
of the present study is to examine the impact of
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sexual dysfunction on NMIBC survivors and to
describe psychosocial characteristics of persons
with differing reported sexual functioning. Given
that three-quarters of new bladder cancer diagno-
ses are de novo NMIBC, these survivors represent
a signiﬁcant population that has been largely
neglected with respect to the effects of cancer and
its treatment on sexual function as a critical com-
ponent in QOL measurement. Furthermore, we
hope to identify speciﬁc points of intervention that
may help reduce the impact of sexual dysfunction
in this group of individuals.
Methods
The current project employed a mixed-methods
design combining an initial quantitative survey
and subsequent qualitative semi-structured inter-
views. For the quantitative study, a convenience
sample of participants (N = 117) was recruited
over two phases. In the ﬁrst phase, veterans from
a large, urban VA tumor registry and patients
from an academic urology clinic patient list were
contacted and screened using an opt-out letter.
Study staff called patients who did not opt out
until (i) potential participants were contacted,
or (ii) ten contact attempts were made. In the
second phase, participants were recruited by
posting an ad on bladder cancer survivorship
websites (e.g., Bladder Cancer Advocacy Net-
work) asking potential respondents to contact
study staff. Potential participants were screened
for study eligibility and eligible participants were
scheduled for a follow-up telephone interview. To
be eligible for inclusion in the study, participants
had to have been diagnosed with NMIBC within
4 years of study entry date.
Participants gave informed consent and were
asked to complete a 45-minute telephone survey
administered by trained interviewers consisting
of several validated measurement tools. Measures
included a validated disease-speciﬁc health-related
quality of life (European Organization for Res-
earch and Treatment of Cancer Quality-of-Life
Questionnaire Bladder Cancer—Superﬁcial—24
[BLS-24]) [11]. The measure has a 7 item sub-scale
for urinary symptoms and 3 item sub-scale for
survivors’ future perspective on their illness. Sexual
function and related concerns were evaluated over
the 4-week period preceding survey completion
using the 8 sexual activity questions included in the
BLS-24.Questions captured level of interest in sex,
frequency of sexual activity, degree of enjoyment,
sexual arousal difﬁculties, intimacy concerns, and
partner contamination concerns related to bladder
cancer treatment. Responses were collected on
a 4-point scale (i.e., Not at all, A little, Quite a
bit, Very much). Survivors’ perceptions of their
cancer’s disruption of their life was measured by
the Illness Intrusiveness Rating Scale (IIRS) [12],
a 13-item measure used in a number of studies of
cancer and chronic disease.The effects of intrusive-
ness stem from the reduction of positive outcomes
from participating in valued life activities and of
the patient’s sense of control over the ability to
obtain positive outcomes or avoid negative ones.
Psychological distress was measured with the Brief
Symptom Index-18 (BSI-18), which includes a total
score and subscales for somatization, depression,
and anxiety [13], andhas beenwidely used in studies
of cancer survivorship. An assessment of partner
communication about cancer-related concerns was
performed using a previously validated 10-item
measure adapted from Porter [14].
Descriptive analyses of the survey results were
carried out using SAS v9.2 (SAS Institute, Cary,
NC). Chi-square tests were used to examine dif-
ferences in respondent characteristics stratiﬁed by
level of sexual interest. In addition, Classiﬁcation
and Regression Tree (CART) methodology was
implemented to classify groups with similar char-
acteristics. A total of 85 patients with complete
covariate information were used to identify groups
of similar individuals and explore relationships
with sexual activity. CART decision tree method-
ology permits the evaluation of unique interac-
tions between subsets of covariates and offers a
visual representation of these relationships. CART
analysis was performed using CART v6.4 software
(Salford Systems, San Diego, CA).
To gain a greater understanding of issues iden-
tiﬁed in the survey, participants for the qualita-
tive study were recruited from the same VA tumor
registry and urology clinic (N = 26). Individuals
were sent opt-out letters, contacted, and screened
using similar eligibility criteria to the quantita-
tive study. While participation in the quantitative
study was not part of the exclusion criteria, no
qualitative participants reported enrollment in
the quantitative study. Study participants gave
informed consent and were asked to complete
a semi-structured interview administered by a
trained qualitative interviewer (HHG) consisting
of diagnosis, treatment, monitoring, symptoms
and management, relationships and sexuality, and
patient navigation. Interviews were audiotaped
and averaged one hour and six minutes in length,
with a range of 48 to 120 minutes.
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Recordings were transcribed verbatim by a
professional transcription service and analyzed
using holistic-content and constant compara-
tive analyses. Two co-authors independently read
each transcript line-by-line and developed codes
and patterns located in the qualitative data (open
coding). These co-authors then conducted several
meetings validating these codes, before jointly
synthesizing related codes into themes. A third
co-author reviewed the thematic coding scheme,
as well as supporting codes and data, in order to
afﬁrm the ﬁnal themes. Related to the current
study, initial codes related to participant state-
ments concerning complete or partial erectile
dysfunction, difﬁculty with vaginal lubrication,
and other aspects of sexual dysfunction post-
treatment. The resulting ﬁnal theme was noted as
“experiences of sexual dysfunction among NMIBC
survivors” and exemplifying quotes to illustrate the
ﬁndings were selected and discussed until 100%
consensus was reached.
Based on these qualitative analyses, participants
were placed along a nonlinear scale of sexual func-
tion from least to most affected. Select excerpts
from the interviews were also retrospectively
mapped to the corresponding terminal nodes of
the CART analysis of survey respondents to
further match speciﬁc individual experiences with
their appropriate levels of sexual interest, disease
intrusiveness, arousal dysfunction, and partner
communication.
Both studies were approved by BCM Institu-
tional Review Board, and participants provided
informed consent.
Results
Table 1 shows the demographic and clinical char-
acteristics of the individuals participating in the
quantitative and qualitative portions of the study.
There were more men (72.6% and 84.6%) than
women, more white participants (94.0% and
80.8%) than other ethnicities, and respondents
were generally older in both arms of the study,
likely due to the epidemiological distribution of
bladder cancer as a disease predominantly affect-
ing men, whites, and older adults. The majority
of participants in the two studies were married
(74.4% and 73.2%). Participant level of education
was well-represented across both quantitative
and qualitative studies. Finally, individuals had
been diagnosed with various tumor stages of non-
muscle-invasive bladder cancer (Ta, Tis, and T1).
Quantitative Survey
Greater than one-half (55.3%) of respondents
reported NMIBC or its treatment had interfered
with their relationship with their spouse or
partner. Over one-third (38.8%) of respondents
reported no sexual activity over the 4 weeks prior
to the survey. The percentage of sexually-inactive
survivors was higher among females than males
(56.0% vs. 31.3%; P = 0.04) but was not different
between survivors diagnosed with Tis compared
to Ta or T1 bladder tumors (P = 0.86). For those
individuals who were sexually active, 60.0% of
males experienced difﬁculty gaining or maintain-
ing an erection and 43.1% of males had problems
with ejaculation (Table 2). Among sexually-active
females, 62.5% experienced problems including
vaginal dryness.
Contamination from bladder cancer treatment
was a signiﬁcant concern among both male and
female respondents that inhibited sexual activity
with their partner. Almost one-quarter (23.2%) of
participants reported some degree of concern over
transmitting disease to their partners. While only
20% of the individuals surveyed reported sharing
all concerns about sexual function with their part-
ners, nearly 50% of participants reported that
it was very helpful to discuss concerns about
sexual function with their partners, with a similar
Table 1 Demographic and clinical characteristics across
quantitative and qualitative study samples
Quantitative
survey
Qualitative
survey
Age (Mean [SD]) 64.6 (9.50) 69.1 (9.40)
N (%) N (%)
Gender
Male 85 (72.6) 22 (84.6)
Female 32 (27.4) 4 (13.4)
Race/ethnicity
White 110 (94.0) 21 (80.8)
Black or African American 2 (1.7) 4 (15.4)
Other 5 (4.3) 1 (3.8)
Marital Status
Married 87 (74.4) 19 (73.2)
Single, never married 3 (2.6) 3 (11.5)
Separated/divorced 17 (14.5) 1 (3.8)
Widowed 10 (8.5) 3 (11.5)
Education
Less than high school 0 (0.0) 2 (7.7)
High school graduate 18 (15.4) 7 (26.9)
Some college 43 (36.8) 8 (30.8)
Bachelor’s degree 32 (27.4) 8 (30.8)
Postgraduate degree 24 (20.4) 0 (0.0)
Unknown 0 (0.0) 1 (3.8)
Tumor stage
Ta 37 (31.6) 8 (30.8)
Tis 15 (12.8) 2 (7.8)
T1 35 (29.9) 5 (19.2)
Did not know/unknown 30 (25.6) 11 (58.2)
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percentage of male and female respondents indi-
cating discussion was helpful (P = 24).
There was a signiﬁcant difference (P = 0.02) in
the time since diagnosis as measured in months
between those surveyed who endorsed at least
some interest in sex (25.4 months) and those
who reported no interest in sex (16.7 months).
However, no other demographic variables were
associated with level of sexual interest, including
relationship status (P = 0.17). Between these two
groups, the difference in the amount of communi-
cation regarding concerns over sexual function
approached signiﬁcance (P = 0.09) based on res-
ponses on a ﬁve-point Likert-type scale (data not
shown). On the other hand, neither degree of
illness intrusiveness (P = 0.47) nor arousal dys-
function (P = 0.64 for men, P = 0.26 for women)
exhibited a signiﬁcant difference between those
who had no interest in sex and those who had at
least some interest in sex.
Survey data were used to formulate a decision
tree with seven terminal nodes in order to group
individuals according to their interest in sexual
activity, level of disease intrusiveness, degree
of arousal dysfunction, and strength of partner
communication (see Figure 1). This analysis
further demonstrated that there were two subsets
of NMIBC survivors who reported the least
sexual activity: (i) survivors indicating any interest
in sex, mild illness intrusiveness, and moderate-
to-severe arousal dysfunction, and (ii) survivors
indicating any interest in sex, severe illness in-
trusiveness and poor communication with their
spouse/partner regarding concerns about sexual
function. Both subsets describe clinically modiﬁ-
able intervention points where sexual medicine
physicians and sex therapists could potentially
intervene.
Table 2 Patient characteristics stratified by level of
sexual interest
No interest
in sex
(N = 17)
At least some
interest in sex
(N = 76)
P(Mean [SD]) (Mean [SD])
Age (years) 65.1 (10.0) 62.5 (8.4) 0.36
Time since diagnosis
(months)
16.7 (10.7) 25.4 (14.1) 0.02
n (%) n (%)
Gender 0.07
Male 9 (13.2) 59 (86.8)
Female 8 (32.0) 17 (68.0)
Education 0.42
High school diploma 4 (23.5) 8 (10.5)
Some college 6 (35.3) 28 (36.8)
Bachelor’s degree 3 (17.7) 24 (31.6)
Graduate school 4 (23.5) 16 (21.1)
Relationship status 0.17
Married 12 (70.6) 64 (84.2)
Not married 5 (29.4) 12 (15.8)
Smoking status 0.45
Current smoker 3 (17.7) 9 (11.8)
Nonsmoker 14 (82.3) 67 (88.2)
Stage of disease 0.76
T0 0 (0.0) 3 (4.3)
Ta 4 (26.7) 23 (32.9)
Tis 2 (13.3) 9 (12.9)
T1 4 (26.7) 22 (31.4)
Unknown/missing 5 (33.3) 13 (18.5)
Node 1
INTEREST: To what extent 
were you interested in sex?
N = 85
Node 2
INTRUSIVE: How much does 
your illness and/or treatment 
interfere with your sex life?
N = 69
Node 4
INTRUSIVE: How much does 
your illness and/or 
treatment interfere with 
your sex life?
N = 46
Node 3
INTEREST: To what extent 
were you interested in sex?
N = 23
Node 6
COMM: How much did you 
talk to your partner about 
concerns  about sexual 
funcon? N = 21
Node 5
AROUSAL DYSFUNCTION: 
Male: Erecle diﬃcules 
Female: Vaginal dryness
N = 25
Terminal Node 1
INTEREST = Not at all
N = 16
Terminal Node 2
INTRUSIVE = Not at all
INTEREST = A lile
N = 12
Terminal Node 3
INTRUSIVE = Not at all
INTEREST ≥ Quite a bit
N = 11
Terminal Node 4
INTEREST ≥ A lile
INTRUSIVE = Mild
AROUSAL ≥ Moderate
N = 6
Terminal Node 5
INTEREST ≥ A lile
INTRUSIVE = Mild
AROUSAL = Mild 
N = 19
Terminal Node 6
INTEREST ≥ A lile
INTRUSIVE ≥Moderate
COMM = Poor
N = 8
Terminal Node 7
INTEREST ≥ A lile
INTRUSIVE ≥Moderate
COMM = Strong
N = 13
During the past 4 weeks:  To what 
extent were you sexually acve?
=  Not At All
=  A Lile
=  Quite A Bit/Very Much
INTEREST = Not at all
INTEREST = A lile, 
Quite a bit, Very Much
INTEREST = A lile
INTEREST = Quite a bit, 
Very Much
INTRUSIVE = Not at all
INTRUSIVE = Mild, 
Moderate, Severe
INTRUSIVE = 
Mild
INTRUSIVE = Moderate, 
Severe
COMM = StrongCOMM = Poor
AROUSAL 
DYSFUNCTION = Mild
AROUSAL 
DYSFUNCTION = 
Moderate, 
Severe
Figure 1 CART analysis demonstrates relationship between NMIBC survivor characteristics and level of sexual activity.
Sexual Dysfunction among BlCa Survivors 145
Sex Med 2014;2:141–151© 2014 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
Conversely, the decision tree illustrated two
groups of NMIBC survivors reporting the most
sexual activity were those who (i) indicated little
to no illness intrusiveness and at least quite a bit
of interest in sex, and (ii) indicated any interest in
sex, severe illness intrusiveness, and strong com-
munication with their spouse/partner regarding
concerns about sexual function.
Description of CART Terminal Nodes and Sexual
Activity among Grouped Individuals
Terminal Nodes 1, 2, and 3 explored the inter-
section of sexual interest, illness intrusiveness, and
sexual activity within the previous 4-week period.
Survey participants whose response patterns indi-
cated that they were “not at all interested in sex”
(n = 16) were also “not at all” sexually active within
the 4-week period preceding their telephone
interview. In contrast, survey participants who
reported having some degree of interest in sex
and no illness intrusiveness varied in terms of
their sexual activity in the previous four weeks.
The majority of survey participants whose
response patterns indicated “a little interest” in sex
and no illness intrusiveness (Terminal Node 2,
n = 12) reported being sexually active “a little” or
“quite a bit/very much” in the last month. Most
survey participants indicating “quite a bit” or “very
much” in sex and no illness intrusiveness (Terminal
Node 3, n = 11) reported being sexually active
“quite a bit/very much” in the last month. No
Terminal Node 3 participants reported sexual
inactivity in the month prior to completing the
survey.
New trends emerged when survey responses
were analyzed in terms of the impact of sexual
interest, illness intrusiveness, and arousal dysfunc-
tion on sexual activity in the previous 4-week
period. Only one half of survey participants who
reported having some degree of interest in sex,
mild illness intrusiveness, and moderate-to-severe
erectile difﬁculties or vaginal dryness (Terminal
Node 4, n = 6) were “a little” sexually active over
the past 4 weeks. The other half of these respon-
dents were “not at all” sexually active. Alterna-
tively, the majority of survey respondents who
reported some degree of interest in sex, but expe-
riencing both mild intrusiveness and arousal dys-
function were sexually active “a little” or “quite a
bit/very much” in the last month (Terminal Node
5, n = 19). Only a small number of survey partici-
pants whose responses corresponded to Terminal
Node 5 reported sexual inactivity in the past
month.
Like the arousal dysfunction variable, commu-
nication between partners affected sexual activity
in the previous 4-week period. Among those
survey respondents with some degree of interest in
sex, but who were experiencing moderate-to-
severe illness intrusiveness, communication was
instrumental in determining their degree of sexual
activity. Participants who reported “poor” com-
munication with their partners or spouses (Termi-
nal Node 6, n = 8) were primarily sexually inactive
within the month preceding the survey. These
ﬁndings were in sharp contrast with survey parti-
cipants who reported “strong” communication
with partners or spouses. Survey participants’
responses corresponding with Terminal Node 7
(n = 13) were those who remained interested in
sexual activity, in spite experiencing moderate-to-
severe illness intrusiveness, and communicated
frequently and comprehensively with partners
about their concerns about sexual functioning.
Terminal Node 7 participants varied in terms of
their sexual activity in the previous 4 weeks.
However, the majority were “a little” or “quite a
bit/very much” active.
Qualitative Study
The information gathered through qualitative
study interview transcripts was used to report
sexual dysfunction and level of affectedness among
NMIBC survivors on a linear scale. A scaled view
of how sexual dysfunction affects NMIBC survi-
vors is presented in Figure 2.
The qualitative data showed that 50% of par-
ticipants interviewed reported physical symptoms
of sexual dysfunction. In addition, greater than
40% of the individuals endorsed a negative impact
on their primary relationships, including perceived
loss of intimacy and divorce. Similar to the quan-
titative study, over 30% of those interviewed
refrained from sexual activity due to a fear of con-
taminating their partner with treatment-related
agents or spreading NMIBC.
Several themes related to sexual dysfunction
and partner interaction that were observed in
CART analysis of quantitative survey participants
were reinforced by responses from the qualitative
survey. Table 3 displays quotations extracted from
the transcripts of qualitative surveys as mapped
onto the CART terminal nodes from survey
respondents. Excerpts from qualitative partici-
pants revealed that individuals with strong partner
communication re-established a sexual relation-
ship after bladder cancer diagnosis and treatment.
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Table 3 Qualitative interview excerpts mapped onto CART terminal nodes from survey respondents
Terminal
node Feeder node concepts
Outcome: Sexual activity
during previous month* Exemplar quotes from qualitative study
1 “Not at all” interested in
sex
“Not at all” sexually active “. . . actually [my] sex life is terrible right now. I don’t have a wife . . . we
split up about the same time I was diagnosed. Although female
companionship wasn’t at the top of my list with those kind of problems
going on . . . if I wanted to [have sex] I would, but it just so happened that
it just really hasn’t been too high on my priority list.” (VA 017)
2 “A little” interested in sex;
No illness intrusiveness
“A little” or “Quite a bit/
Very much” sexually
active
“It hasn’t affected our relationship at all. I don’t have any problem having an
erection. . . . I’m [in my late fifties], I don’t go out thinking about sex every
day . . . but I don’t have no problem with thinking about sex when I want
to think about it or have any other physical problem yet.” (VA008)
3 “Quite a bit/Very much”
interested in sex; No
illness intrusiveness
“Quite a bit/Very much”
sexually active; None
reported sexual
inactivity
“. . . We still have the same sexual relationship and quite active . . . a
couple times a week . . . there’s no liquid or anything. But you still have
the same sensation and like I said she’s not missing any orgasms at all,
so . . . we got, you know all these aids and pumps and different things
we’ve tried, but we still, we’ve got, we could write a book on that so that’s
not really a problem. We just get it on and been doing that for, since [the
sixties] . . . Sometimes we use [a pump], sometimes we don’t. And like I
say we still have fun and achieve satisfaction in both parties. . . . There’s,
like I said I’m still got that drive and I’m always aggravating her [for sex].”
(BCM015)
4 “Quite a bit/Very much”
interested in sex;
“Moderate-to-severe”
arousal difficulties; Mild
illness intrusiveness
“A little” or “Not at all”
sexually active
“Well obviously for sex it’s different. . . . As far as the marriage goes, it
really made it stronger. Like I say she was there for me the whole time.
And I think we bonded a little closer even. We’ve been married for [over
two decades], so it’s, I mean we were pretty close before that. And
obviously [bladder cancer] changed our sex life a little bit. We still have
sex, but it’s a little different now. . . . It’s, well obviously it’s different for
me. Since I can’t have normal intercourse, but other than that, I mean for
me it’s a lot of foreplay, but I enjoy that too. It’s, you know I, if you’d have
told me before this that I would’ve still enjoyed sex, I might’ve not known
it. But it’s still, I mean it’s okay. It’s not as good as it was before, but it’s
still pretty good. . . . And also now, I guess I can say it, [I] bought a
vibrator so. . . . She can still have orgasms, which it’s, it changed the
dynamics of sex a little bit for me though, it’s. You know now it’s more to
make sure that she has an orgasm. . . . Cause I can’t, so now it’s my
enjoyment for her to have one. But I still enjoy sex, so it’s not like I don’t
want to do it.” (VA010)
5 “A little/Quite a bit/Very
much” interested in
sex; “Mild” arousal
difficulties; Mild illness
intrusiveness
“A little” or “Quite a bit/
Very much” sexually
active in; Only 3
reported sexual
inactivity
“I can’t tell that [bladder cancer treatment] made any difference [in our sex
lives]. I wouldn’t say that there’s been any change . . . There’s no change
that I can tell . . . I more or less abstained [from sex] for about six weeks.
It was a couple weeks after the completion of [BCG] treatment. I was
leery of having had that chemical in there not knowing what it was. I think
it was just voluntarily that we suspended intercourse during the period of
treatment for a couple weeks thereafter and then resumed it . . . there’s
no difference now.” (BCM011)
6 “A little/Quite a bit/Very
much” interested in sex;
“Moderate-to-severe”
illness intrusiveness;
“Poor” communication
Primarily sexually inactive;
Only 2 reported “A little”
sexual activity
“The most difficult part about having bladder cancer is not being able to
have, not being, not being able to be intimate with my husband. . . . I
can’t have intercourse [post-radical cystectomy]. And yeah, I realized that
my husband is still a young man, you know. You know, you know he tries.
He, you know he says it doesn’t bother him and he’s accepted it, you
know. It kinda bothers me because, you know [pause] I just, I, it bothers
me.” (VA022)
“It has affected our marriage very badly . . . sometime it’s almost a platonic
relationship. Neither one of us are eighteen-year-old little buddies. We’re
in our sixties, sixty-nine, sixty-eight, you know . . . which would slow down
anyway, but it shouldn’t stop, which it has done.” (VA004)
7 “A little/Quite a bit/Very
much” interested in sex;
“Moderate-to-severe”
illness intrusiveness;
“Strong” communication
Majority reported “A little”
or “Quite a bit/Very
much” sexual activity
“I thought I better hurry up and do something because I didn’t want to leave
everything a mess whenever I die, see . . . I use a pump tool . . . and
that’s even now, even today it’s quite satisfying. I fussed at her because
before we were married, it was every week. After we were married, it
slowed down, and I’d fuss at her about that.” (VA002)
“Well I have already told you about the respect that I have gained for my
husband and his attention and so on, and our [sexual] relations are not
what they were, but they still are [happening], and so [my urologist]
laughed at us. My daughter was in there with us and he sent her out so
he could talk about sex [with us]. Hahaha. And so [my urologist] said it
wasn’t very many of my patients that are . . . still concerned about sex.
I said well, to each his own. Hahaha. [We have sex] weekly. . . . It’s more
careful now. . . . I make sure that I have on a fresh pad so I have plenty
of room if I should squirt. . . . In fact, [my husband is] kind of amused with
the whole thing sometimes. I say oh . . . I think I’m leaking. Hahaha. He
says well you sprung a leak.” (BCM016)
*Outcomes reported by quantitative study participants.
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Discussion
The data on sexual dysfunction, psychological
burden of disease, and the relationship between
the two, among bladder cancer patients are
limited. Most studies of sexual dysfunction and
other aspects of HRQOL focus on cystectomy
patients. The present study is the ﬁrst to employ
a mixed-methods approach to examine sexual
dysfunction and its psychosocial correlates among
a sample of NMIBC survivors, the largest group
of new bladder cancer diagnoses. Results revealed
the frequency of sexual dysfunction was consider-
able. First, the physical manifestation of sexual
dysfunction, e.g., ED and ejaculatory problems
among men and vaginal dryness among women,
was reported in more than one-half of sexually-
active NMIBC survivors. Study ﬁndings also
demonstrated signiﬁcant psychological and emo-
tional burden. Responses from the two studies
indicate that participants viewed their NMIBC
diagnoses and treatment-related sequelae as
negatively impacting their relationship with their
partner, including loss of intimacy. Additionally,
participants in both study arms reported worry-
ing about harming their partner through sexual
contact following NMIBC treatment. Lastly,
results from CART analysis underlined the im-
portance of effective partner communication in
modifying and maintaining sexual intimacy in the
relationship, particularly among those that per-
ceived NMIBC and its treatment as intrusive in
their sex life. With our cross-sectional, small con-
venience sample approach, these results may not
represent the wider population of bladder cancer
survivors. However, our results suggest these
issues are worthy of further exploration in the
clinic and in population-based studies of survivors.
Sexual Dysfunction and Bladder Cancer
In a nationally representative sample of 1,550
women and 1,455 men aged 57–85, an age group
similar to the study population, physical symp-
toms of sexual dysfunction (e.g., difﬁculty achiev-
ing orgasm) were reported by approximately 35%
of individuals surveyed [15]. Previous research also
suggests that NMIBC treatment is associated with
at least transient sexual dysfunction [5,7]. Results
from the present study support previous ﬁndings
detailing sexual dysfunction and its etiology in this
population. The study participants in the quan-
titative study reported limited sexual activity.
Consistent with previous ﬁndings, nearly 40% of
respondents reported not engaging in any sexual
contact over the 4 weeks preceding survey comple-
tion [16]. Additionally, in both quantitative and
qualitative studies, over one-half of sexually-active
individuals experienced some degree of sexual
dysfunction.
In these two study samples, co-morbid condi-
tions, the natural effects of aging, and NMIBC
treatment and monitoring impact sexual function-
ing and intimacy in relationships. The cancer con-
tinuum model introduced by Flynn exempliﬁes
the physical, emotional and psychological difﬁ-
culties that arise in conjunction with ongoing
management of this complex disease process [17].
Given the multifaceted biopsychosocial issues that
impact sexual functioning in this population, the
question remains how best to address each of the
aforementioned issues surrounding sexual acti-
vity in the face of NMIBC. Discussion of sexual
side-effects and management strategies should be
incorporated into pre-treatment, patient-provider
communication, and continue throughout treat-
ment and monitoring.
Women’s Issues
Women’s experiences are especially underreported
in the scientiﬁc literature. Female NMIBC sur-
vivors may have differing needs following their
diagnosis and throughout subsequent surveillance
and treatment for their disease process. Research
has previously noted that women tend to report
decreased sexual activity when compared to men
across all ages, and more likely that they do not
value penetrative sex as much as men. However,
sexual health continues to play a signiﬁcant role in
female QOL issues [18,19].
Both physical and emotional factors, such as a
decrease in sexual attractiveness, may inﬂuence
sexual life among women. Zippe et al. surveyed
women who underwent radical cystectomy for
muscle-invasive bladder cancer and demonstrated
that 48% of subjects reported sexual dysfunction
due to physical inability, and 30% expressed a
decreased desire for sexual activity due to appre-
hension related to “imperfection” (i.e., urostomy)
[20]. While women suffering from NMIBC may
not experience the level of invasiveness associated
with radical cystectomy and reconstruction, they
continue to undergo procedures that may contrib-
ute to physical and emotional responses affecting
ongoing sexual activity.
As mentioned previously, ED and vaginal
dryness may precipitate an “identity dilemma.”
However, psychosocial and emotional responses
related to this shift in self-perception require
skilled navigation in order to ﬁndnewways of being
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sexual. Wittmann et al. reviews the various phy-
siologic therapies that are available to aid mens’
sexual function [19] Common ED treatments
include pharmacologic (e.g., Phosphodiesterase
Type-5 inhibitors and Alprostadil), mechanical
(e.g., vacuum devices), and prosthetic aids, or some
combination of these therapies. Fewer resources
are available to women with cancer [21], although
since bladder cancer is not a hormonally driven
cancer, hormone replacement therapy consultation
with a gynecologist may be valuable.
Despite the variety of options available for the
physiologic treatment of sexual dysfunction as a
result of NMIBC, the psychological implications
may represent even more of a conundrum. The
loss of a man’s erections or prematurely deve-
loped vaginal dryness may be painful and confusing
resulting in grief and mourning. The psychological
defenses typically used to fend off feelings of grief
tend to generalize and subdue other emotions (e.g.,
sexual desire). If men andwomenwithNMIBC feel
safe and can share their vulnerability and grief with
their partners, they will be in a better position to
stay in touch with their sexual feelings. The ability
to replace longing for spontaneity with intentional
sexual activity will reduce anxiety and result in
greater experience of pleasure [19]. In our sample,
participants who reported at least some interest in
sexwere farther removed from their initialNMIBC
diagnosis than those reporting no interest. We
hypothesize that the participantswith greater inter-
est in sex might have been farther along in their
grief process as described in Wittmann’s model of
sexual rehabilitation.
Given the physiological and psychological
complexity associated with sexual health amongst
cancer survivors, it is necessary to consider multi-
disciplinary care. Social workers are trained to
facilitate grief and can provide additional guidance
with case management, health information, and
patient navigation necessary to address the array
of sexual health concerns found in our sample.
While it is valuable to alert patients about the
sexual side-effects of treatment and the options
for regaining sexual activity, patients may wish to
address their sexual concerns at some distance
from diagnosis when they have come to terms with
the changes brought about by treatment and wish
to become sexually active again.
Partner Communication and Maintaining Sexual
Health in NMIBC Survivors
Our quantitative survey, CART analysis, and sub-
sequent qualitative study all reinforce the impor-
tance of strong communication in maintaining
sexual health between the patient and his/her
partner. Open discussion may often overcome
the effects of illness intrusiveness and physiologic
dysfunction to promote ongoing sexual activity.
Unfortunately, our ﬁndings demonstrate that par-
ticipants rarely disclosed all of their sexual-health-
related concerns to their partners.
Previous research indicates cancer survivors
may be uncomfortable with or not understand
how to discuss their sexual functioning with their
partners [22,23]. Education about the effect of
treatment on sexuality and encouragement of
communication about sexual concerns should be
provided as a part of usual care. Sex therapy may
also help survivors adjust to new sexual realities
and allow survivors to expand their sexual reper-
toire to include non-penetrative sex when penetra-
tion is no longer an option. Accurate information
about the non-transmissibility of toxic treatment
agents from partner to partner through sex should
be provided so that couples can feel reassured and
not avoid sexual activity.
Conclusions
Non-muscle-invasive bladder cancer, its treatment
or both, as well as comorbid conditions may result
in sexual problems. The cross-sectional nature
of our data does not permit comparisons of
sexual functioning or psychological status before
and after diagnosis bladder cancer. However, the
dearth of information about sexual functioning
among NMIBC survivors, particularly women,
heightens the utility of our data for generating
hypotheses for further work. The ﬁndings of the
present study inform the scientiﬁc literature and
clinical practice about the pervasiveness of these
symptoms and their impact on NMIBC survivors’
sexual and romantic relationships. Further work is
needed to design symptom management and edu-
cational programs to dispel misinformation about
contamination by treatment agents and to encour-
age greater communication between partners and
with health care providers about sexual concerns.
Interventions that address sexuality after treat-
ment should be developed to improve this impor-
tant and often ignored aspect of quality of life of
NMIBC survivors.
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